secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2025-03-07T23:59:59+00:00
Accession:  0001493152-25-009549
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Naya Biosciences postpones 2024 annual meeting to April 9, 2025; all prior votes void
--------------------------------------------------------------------------------

- Annual meeting postponed from March 10 to April 9, 2025; new record date set for March 10, 2025.
- Standard proposals (director election, auditor ratification) have sufficient votes; special proposals (share issuance, plan amendment, authorized shares) lack required votes.
- All votes cast under the February proxy are null and void; new proxy card will be issued.
- Nasdaq granted extension until June 30, 2025 to regain compliance with annual meeting rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315225009549/0001493152-25-009549-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315225009549/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009549

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer